Gabriele Gugliotta
- Hematology top 1%
- Chronic Myeloid Leukemia Treatments 44
- Acute Myeloid Leukemia Research 6
- Genetics top 1%
- Chronic Lymphocytic Leukemia Research 40
- Rheumatology top 2%
- Eosinophilic Disorders and Syndromes 22
-
- Lymphoma Diagnosis and Treatment 9
-
- Acute Lymphoblastic Leukemia research 5
-
- CNS Lymphoma Diagnosis and Treatment 3
-
- Endoplasmic Reticulum Stress and Disease 3
- Co-authors
- Fausto CastagnettiMichele BaccaraniGianantonio RostiFrancesca PalandriSimona SoveriniGiovanni MartinelliMichèle CavoMarkus Pfirrmann
- Cited by
- HematologyGeneticsRheumatology
- Partner nations
- ItalyUnited StatesGermany
In The Last Decade
Gabriele Gugliotta
56 papers receiving 1.1k citations
Peers
Comparison fields: 5 of 67
- Hematology 857
- Genetics 704
- Rheumatology 377
- Pathology and Forensic Medicine 108
- Oncology 160
Countries citing papers authored by Gabriele Gugliotta
This map shows the geographic impact of Gabriele Gugliotta's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Gabriele Gugliotta with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Gabriele Gugliotta more than expected).
Fields of papers citing papers by Gabriele Gugliotta
This network shows the impact of papers produced by Gabriele Gugliotta. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Gabriele Gugliotta. The network helps show where Gabriele Gugliotta may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Gabriele Gugliotta, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 0 | |
| 2 | 2024 | 0 | |
| 3 | 2023 | 0 | |
| 4 | 2022 | 14 | |
| 5 | 2022 | 6 | |
| 6 | 2022 | 4 | |
| 7 | 2016 | 7 | |
| 8 | 2016 | 124 | |
| 9 | 2015 | 110 | |
| 10 | 2014 | 31 | |
| 11 | 2014 | 3 | |
| 12 | 2013 | 18 | |
| 13 | 2013 | 16 | |
| 14 | 2011 | 4 | |
| 15 | 2011 | 20 | |
| 16 | 2010 | 32 | |
| 17 | 2009 | 1 | |
| 18 | 2009 | 26 | |
| 19 | 2009 | 54 | |
| 20 | 2007 | 20 |
About Gabriele Gugliotta
Gabriele Gugliotta is a scholar working on Hematology, Genetics and Rheumatology, having authored 60 papers that have together received 1.1k indexed citations. Recurring topics across this work include Chronic Myeloid Leukemia Treatments (44 papers), Chronic Lymphocytic Leukemia Research (40 papers), Eosinophilic Disorders and Syndromes (22 papers), Lymphoma Diagnosis and Treatment (9 papers), Acute Myeloid Leukemia Research (6 papers), Acute Lymphoblastic Leukemia research (5 papers), CNS Lymphoma Diagnosis and Treatment (3 papers) and Endoplasmic Reticulum Stress and Disease (3 papers). The work is most often cited by research in Hematology (857 citations), Genetics (704 citations) and Rheumatology (377 citations). Gabriele Gugliotta has collaborated with scholars based in Italy, United States and Germany. Frequent co-authors include Fausto Castagnetti, Michele Baccarani, Gianantonio Rosti, Francesca Palandri, Simona Soverini, Giovanni Martinelli, Michèle Cavo, Markus Pfirrmann, Manuela Mancini and Marilina Amabile. Their work appears in journals such as Blood, Oncotarget, Leukemia, Haematologica and Journal of Cellular Biochemistry.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.